News & Media

November 27, 2013

It’s not quite the tricorder that doctors in the legendary sci-fi series Star Trek would use to instantly assess a patient’s condition, but it’s close. A small electronic device can continuously track the level of medicines in an animal’s bloodstream. If it works in people, the device could revolutionize how medicines such as anticancer compounds and antibiotics are monitored and administered for life-threatening conditions. Co-Director H. Tom Soh and colleagues describe this work, part of the Garland Initiative for Vision, Science Translational Medicine (featured cover story).

October 02, 2013

October 2nd is Stem Cell Awareness Day, which brings together organizations and individuals around the world in support of stem cell research, with the aim of increasing awareness and education. UC Santa Barbara stem cell researchers are presenting educational outreach seminars at Santa Barbara High School, San Marcos High School, Cate School, and Santa Barbara City College. In addition, tours of the Laboratory for Stem Cell Research and Engineering, our CIRM-funded core facility, are offered to local community groups to provide a glimpse of the exciting ongoing research on human pluripotent stem cells. For more information, see

August 17, 2013

In the latest rankings by the Centre for Science and Technology Studies at Leiden University in the Netherlands, UC Santa Barbara has placed second on the annual list of the top 500 major universities in the world in terms of impact in the field of the sciences.

August 12, 2013

Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from UC Santa Barbara, the Morgridge Institute for Research at the University of Wisconsin–Madison, and Northwestern University have created an efficient way to target and repair defective genes.

Published today in the Proceedings of the National Academy of Sciences, the team’s findings demonstrate that the novel technique is much simpler than previous methods and establishes the groundwork for major advances in regenerative medicine, drug screening, and biomedical research.

Principal investigator James A. Thomson, co-director of biology at UCSB’s Center for Stem Cell Biology and Engineering and professor in the campus’s Department of Molecular, Cellular and Developmental Biology, said the discovery holds many practical applications, including paving a new route for correcting genetic disorders. Thomson is also director of regenerative biology at the Morgridge Institute, serves as the James Kress Professor of Embryonic Stem Cell Biology at the University of Wisconsin–Madison, and is a John D. MacArthur professor at UW–Madison’s School of Medicine and Public Health.

August 06, 2013

Graduate students Britney Pennington (BMSE) and Lyndsay Leach (MCDB) are the recipients of new fellowships in support of stem cell research in the Clegg lab in the Center for Stem Cell Biology and Engineering. Britney will receive the Richard & Katherine Gee Breaux Fellowship in Vision Research to support her research project aimed at developing novel biomimetic substrates for growth and differentiation of stem cells. Lyndsay, who hails from the state of Vermont, will receive a Vermont Community Foundation Fellowship to investigate the mechanism of retinal pigmented epithelium (RPE) differentiation and develop protocols to convert stem cells to RPE. Stem cell-derived RPE is a promising candidate for the treatment of macular degeneration.